Abiopharma

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors

Coherent Introduces Next-Generation Polarization-Maintaining Optical Fiber

Oil-Dri to Host First Quarter 2026 Earnings Discussion and Fiscal Year 2025 Annual Meeting of Stockholders via Live Webcast

BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

Ekso Bionics Reports Third Quarter 2025 Financial Results

Arcus Biosciences Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update

Vivani Medical, Inc. Announces Closing of Common Stock Offering

Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025

Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025